Search

Donna A. Jagoe

Examiner (ID: 8925)

Most Active Art Unit
1614
Art Unit(s)
1614, 1619
Total Applications
644
Issued Applications
169
Pending Applications
182
Abandoned Applications
293

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7027033 [patent_doc_number] => 20050020674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Pharmaceutical compositions of short-acting sedative hypnotic agent' [patent_app_type] => utility [patent_app_number] => 10/895603 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6490 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020674.pdf [firstpage_image] =>[orig_patent_app_number] => 10895603 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/895603
Pharmaceutical compositions of short-acting sedative hypnotic agent Jul 20, 2004 Issued
Array ( [id] => 5711044 [patent_doc_number] => 20060052389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects' [patent_app_type] => utility [patent_app_number] => 10/894349 [patent_app_country] => US [patent_app_date] => 2004-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 20971 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052389.pdf [firstpage_image] =>[orig_patent_app_number] => 10894349 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/894349
Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects Jul 18, 2004 Abandoned
Array ( [id] => 7265166 [patent_doc_number] => 20040242702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Glutaraldehyde composition' [patent_app_type] => new [patent_app_number] => 10/485070 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2762 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242702.pdf [firstpage_image] =>[orig_patent_app_number] => 10485070 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/485070
Glutaraldehyde composition Jul 12, 2004 Abandoned
Array ( [id] => 6972308 [patent_doc_number] => 20050038018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Meloxicam compositions' [patent_app_type] => utility [patent_app_number] => 10/885260 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6050 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038018.pdf [firstpage_image] =>[orig_patent_app_number] => 10885260 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/885260
Meloxicam compositions Jul 5, 2004 Abandoned
Array ( [id] => 7276410 [patent_doc_number] => 20040235861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Method of using flibanserin for neuroprotection' [patent_app_type] => new [patent_app_number] => 10/882613 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2419 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235861.pdf [firstpage_image] =>[orig_patent_app_number] => 10882613 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/882613
Method of using flibanserin for neuroprotection Jun 30, 2004 Abandoned
Array ( [id] => 92278 [patent_doc_number] => 07737147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/881911 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5975 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737147.pdf [firstpage_image] =>[orig_patent_app_number] => 10881911 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/881911
Methods and compositions to enhance the efficacy of phosphodiesterase inhibitors Jun 29, 2004 Issued
Array ( [id] => 7265438 [patent_doc_number] => 20040242974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Treatment of refractory depression with an opiate antagonist and an antidepressant' [patent_app_type] => new [patent_app_number] => 10/878285 [patent_app_country] => US [patent_app_date] => 2004-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7492 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242974.pdf [firstpage_image] =>[orig_patent_app_number] => 10878285 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/878285
Treatment of refractory depression with an opiate antagonist and an antidepressant Jun 28, 2004 Abandoned
Array ( [id] => 7156550 [patent_doc_number] => 20050026979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Methods for treating inflammation and inflammation-associated diseases with a statin and ether' [patent_app_type] => utility [patent_app_number] => 10/872023 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15495 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026979.pdf [firstpage_image] =>[orig_patent_app_number] => 10872023 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/872023
Methods for treating inflammation and inflammation-associated diseases with a statin and ether Jun 17, 2004 Abandoned
Array ( [id] => 6996339 [patent_doc_number] => 20050136117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 10/868104 [patent_app_country] => US [patent_app_date] => 2004-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5965 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136117.pdf [firstpage_image] =>[orig_patent_app_number] => 10868104 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/868104
Pharmaceutical formulations Jun 14, 2004 Abandoned
Array ( [id] => 5913720 [patent_doc_number] => 20060128782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/559252 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3619 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128782.pdf [firstpage_image] =>[orig_patent_app_number] => 10559252 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559252
Sublingual Formulations of Ketorolac or Salts Thereof May 25, 2004 Issued
Array ( [id] => 7005803 [patent_doc_number] => 20050171116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Enhancing the efficacy of tubercular drugs' [patent_app_type] => utility [patent_app_number] => 10/851601 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3651 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171116.pdf [firstpage_image] =>[orig_patent_app_number] => 10851601 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/851601
Enhancing the efficacy of tubercular drugs May 20, 2004 Abandoned
Array ( [id] => 7465851 [patent_doc_number] => 20040198633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Identifying parasitic fungi of the organism, and treatment thereof' [patent_app_type] => new [patent_app_number] => 10/478508 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2203 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198633.pdf [firstpage_image] =>[orig_patent_app_number] => 10478508 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/478508
Identifying parasitic fungi of the organism, and treatment thereof May 10, 2004 Abandoned
Array ( [id] => 7190443 [patent_doc_number] => 20040204399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Aerosolized decongestants for the treatment of sinusitis' [patent_app_type] => new [patent_app_number] => 10/835872 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15824 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204399.pdf [firstpage_image] =>[orig_patent_app_number] => 10835872 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/835872
Aerosolized decongestants for the treatment of sinusitis Apr 28, 2004 Abandoned
Array ( [id] => 5154952 [patent_doc_number] => 20070037835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid' [patent_app_type] => utility [patent_app_number] => 10/554560 [patent_app_country] => US [patent_app_date] => 2004-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3771 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037835.pdf [firstpage_image] =>[orig_patent_app_number] => 10554560 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/554560
Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid Apr 26, 2004 Abandoned
Array ( [id] => 7467366 [patent_doc_number] => 20040198839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Cardioprotective dosage units' [patent_app_type] => new [patent_app_number] => 10/828797 [patent_app_country] => US [patent_app_date] => 2004-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2339 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198839.pdf [firstpage_image] =>[orig_patent_app_number] => 10828797 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/828797
Cardioprotective dosage units Apr 20, 2004 Abandoned
Array ( [id] => 6967203 [patent_doc_number] => 20050234100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Insulin resistance as new action of loperamide' [patent_app_type] => utility [patent_app_number] => 10/826258 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5282 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20050234100.pdf [firstpage_image] =>[orig_patent_app_number] => 10826258 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/826258
Insulin resistance as new action of loperamide Apr 18, 2004 Abandoned
Array ( [id] => 7435562 [patent_doc_number] => 20040266806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Pharmaceutical formulation' [patent_app_type] => new [patent_app_number] => 10/821811 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9952 [patent_no_of_claims] => 209 [patent_no_of_ind_claims] => 78 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266806.pdf [firstpage_image] =>[orig_patent_app_number] => 10821811 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/821811
Pharmaceutical formulation Apr 7, 2004 Abandoned
Array ( [id] => 7329740 [patent_doc_number] => 20040254100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Use of thiostrepton as an anti-mycobacterial agent' [patent_app_type] => new [patent_app_number] => 10/182658 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1473 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254100.pdf [firstpage_image] =>[orig_patent_app_number] => 10182658 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/182658
Use of thiostrepton as an anti-mycobacterial agent Apr 4, 2004 Abandoned
Array ( [id] => 7672940 [patent_doc_number] => 20040180839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'D-mannose contraceptives' [patent_app_type] => new [patent_app_number] => 10/810522 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1019 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180839.pdf [firstpage_image] =>[orig_patent_app_number] => 10810522 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/810522
D-mannose contraceptives Mar 25, 2004 Abandoned
Array ( [id] => 5142511 [patent_doc_number] => 20070004727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Use of compounds for the prevention of drug-induced cell toxicity' [patent_app_type] => utility [patent_app_number] => 10/550488 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10065 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004727.pdf [firstpage_image] =>[orig_patent_app_number] => 10550488 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550488
Use of compounds for the prevention of drug-induced cell toxicity Mar 24, 2004 Abandoned
Menu